Home
- Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P.
- Natrol Appoints Vincent Andrich VP Sales for Prolab Division
- Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results
- Body Shop Reports 24.8 Mil Euro Sales Revenues
- Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label
- Supplement Group Targets Consumer Education
- Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth
- Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO
- drugstore.com Expects to Reach Profitability Target in 2003
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- Natural Health Trends Corp. Launches Lexxus Taiwan
- FDA Presents Compliance Guide for Structure/Function Claims
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- Cyanotech Names Bob Capelli as Director of Sales
- Nutrient Supplementation Reduces Irregular Heartbeat (Arrhythmia) in Patients
A randomized, double-blind, placebo-controlled, multi-center study, published in the November 2005 issue of JANA, indicates that nutrient supplementation led to a statistically significant decrease in the frequency of clinically apparent arrhythmic episodes, with further improvement in frequency over time.
- Nutrient Supplementation Reduces Irregular Heartbeat (Arrhythmia) in Patients
A randomized, double-blind, placebo-controlled, multi-center study, published in the November 2005 issue of JANA, indicates that nutrient supplementation led to a statistically significant decrease in the frequency of clinically apparent arrhythmic episodes, with further improvement in frequency over time.
- Nutrient Supplementation Reduces Irregular Heartbeat (Arrhythmia) in Patients
A randomized, double-blind, placebo-controlled, multi-center study, published in the November 2005 issue of JANA, indicates that nutrient supplementation led to a statistically significant decrease in the frequency of clinically apparent arrhythmic episodes, with further improvement in frequency over time.
- Nutrient Supplementation Reduces Irregular Heartbeat (Arrhythmia) in Patients
A randomized, double-blind, placebo-controlled, multi-center study, published in the November 2005 issue of JANA, indicates that nutrient supplementation led to a statistically significant decrease in the frequency of clinically apparent arrhythmic episodes, with further improvement in frequency over time.
- Nutrient Supplementation Reduces Irregular Heartbeat (Arrhythmia) in Patients
A randomized, double-blind, placebo-controlled, multi-center study, published in the November 2005 issue of JANA, indicates that nutrient supplementation led to a statistically significant decrease in the frequency of clinically apparent arrhythmic episodes, with further improvement in frequency over time.
- Biogaia Releases Results From Allergy Study
Study done in collaboration with the Centre for Allergy Research at the Karolinska Institutet and including 232 newborn infants at four paediatric allergy clinics in Sweden, showed that babies that were supplemented with Reuteri showed significantly higher levels of the live bacteria in their gastrointestinal tracts, but the incidence of eczema , the main clinical manifestations of allergy in the first 2 years of life was, however, not significantly affected by supplementation with Reuteri.
- Biogaia Releases Results From Allergy Study
Study done in collaboration with the Centre for Allergy Research at the Karolinska Institutet and including 232 newborn infants at four paediatric allergy clinics in Sweden, showed that babies that were supplemented with Reuteri showed significantly higher levels of the live bacteria in their gastrointestinal tracts, but the incidence of eczema , the main clinical manifestations of allergy in the first 2 years of life was, however, not significantly affected by supplementation with Reuteri.
- Biogaia Releases Results From Allergy Study
Study done in collaboration with the Centre for Allergy Research at the Karolinska Institutet and including 232 newborn infants at four paediatric allergy clinics in Sweden, showed that babies that were supplemented with Reuteri showed significantly higher levels of the live bacteria in their gastrointestinal tracts, but the incidence of eczema , the main clinical manifestations of allergy in the first 2 years of life was, however, not significantly affected by supplementation with Reuteri.
- Biogaia Releases Results From Allergy Study
Study done in collaboration with the Centre for Allergy Research at the Karolinska Institutet and including 232 newborn infants at four paediatric allergy clinics in Sweden, showed that babies that were supplemented with Reuteri showed significantly higher levels of the live bacteria in their gastrointestinal tracts, but the incidence of eczema , the main clinical manifestations of allergy in the first 2 years of life was, however, not significantly affected by supplementation with Reuteri.
- L-Arginine Therapy Examined in Acute Myocardial Infarction
Research published in JAMA describes a study involving subjects who had had heart attacks and continued to have symptoms of heart disease, supplemented with L-arginine.
- L-Arginine Therapy Examined in Acute Myocardial Infarction
Research published in JAMA describes a study involving subjects who had had heart attacks and continued to have symptoms of heart disease, supplemented with L-arginine.
- Should The Public Be Wary of Arginine Supplements
Bill Sardi comments on the January 4 issue of the Journal of the American Medical Association which reported that L-arginine supplementation resulted in the deaths of six patients versus none in an un-supplemented group.
- Should The Public Be Wary of Arginine Supplements
Bill Sardi comments on the January 4 issue of the Journal of the American Medical Association which reported that L-arginine supplementation resulted in the deaths of six patients versus none in an un-supplemented group.
- Vitamin D Supplementation During Pregnancy Could Reduce Osteoporosis In Children
Study published in this week’s issue of
The Lancet indicates that children whose mothers were lacking in vitamin D during
pregnancy grow up to have weaker bones.
- Vitamin D Supplementation During Pregnancy Could Reduce Osteoporosis In Children
Study published in this week’s issue of
The Lancet indicates that children whose mothers were lacking in vitamin D during
pregnancy grow up to have weaker bones.
- Vitamin D Supplementation During Pregnancy Could Reduce Osteoporosis In Children
Study published in this week’s issue of
The Lancet indicates that children whose mothers were lacking in vitamin D during
pregnancy grow up to have weaker bones.
- Vitamin D Supplementation During Pregnancy Could Reduce Osteoporosis In Children
Study published in this week’s issue of
The Lancet indicates that children whose mothers were lacking in vitamin D during
pregnancy grow up to have weaker bones.
- Research Examines Effect of Enzymotec Product on Children's Cognitive Performance
Double-blind, placebo-controlled clinical study conducted at the Tel-Aviv Sourasky Medical Center on 90 ADHD children indicates lipid-based product significantly improves cognitive performance.
- Research Examines Effect of Enzymotec Product on Children's Cognitive Performance
Double-blind, placebo-controlled clinical study conducted at the Tel-Aviv Sourasky Medical Center on 90 ADHD children indicates lipid-based product significantly improves cognitive performance.
- Research Examines Effect of Enzymotec Product on Children's Cognitive Performance
Double-blind, placebo-controlled clinical study conducted at the Tel-Aviv Sourasky Medical Center on 90 ADHD children indicates lipid-based product significantly improves cognitive performance.
- Research Examines Effect of Enzymotec Product on Children's Cognitive Performance
Double-blind, placebo-controlled clinical study conducted at the Tel-Aviv Sourasky Medical Center on 90 ADHD children indicates lipid-based product significantly improves cognitive performance.
- Research Examines Effect of Enzymotec Product on Children's Cognitive Performance
Double-blind, placebo-controlled clinical study conducted at the Tel-Aviv Sourasky Medical Center on 90 ADHD children indicates lipid-based product significantly improves cognitive performance.
- ForsLean Favorably Alters Body Composition According to Study Published in the Journal of the International Society of Sports Nutrition
A study published in the December 2005 Journal of the International Society of Sports Nutrition (www.theissn.org) entitled "Effects of Coleus forskohlii extract supplementation on body composition and markers of health in sedentary overweight females" confirmed that ForsLean(R), Sabinsa Corporation's patented Coleus forskohlii extract promotes favorable changes in body composition.
- ForsLean Favorably Alters Body Composition According to Study Published in the Journal of the International Society of Sports Nutrition
A study published in the December 2005 Journal of the International Society of Sports Nutrition (www.theissn.org) entitled "Effects of Coleus forskohlii extract supplementation on body composition and markers of health in sedentary overweight females" confirmed that ForsLean(R), Sabinsa Corporation's patented Coleus forskohlii extract promotes favorable changes in body composition.
- Quebec, Ontario Researchers to do Study on Treating Depression with Omega-3
In a study that will finish in the fall of 2007 and will receive funding from the European company Isodisnatura, Canadian researchers are examining the effect of omega-3 from fish oil and its ability to treat major depression.
- Quebec, Ontario Researchers to do Study on Treating Depression with Omega-3
In a study that will finish in the fall of 2007 and will receive funding from the European company Isodisnatura, Canadian researchers are examining the effect of omega-3 from fish oil and its ability to treat major depression.
- Curry and Cauliflower Could Halt Prostate Cancer
Scientists test turmeric and phenethyl isothiocyanate (PEITC) in mice, injecting the mice with cells from human prostate cancer cell lines to grow tumors against which the compounds could be tested, finding that injections of both compounds together significantly retarded tumor growth.
- Curry and Cauliflower Could Halt Prostate Cancer
Scientists test turmeric and phenethyl isothiocyanate (PEITC) in mice, injecting the mice with cells from human prostate cancer cell lines to grow tumors against which the compounds could be tested, finding that injections of both compounds together significantly retarded tumor growth.
- Curry and Cauliflower Could Halt Prostate Cancer
Scientists test turmeric and phenethyl isothiocyanate (PEITC) in mice, injecting the mice with cells from human prostate cancer cell lines to grow tumors against which the compounds could be tested, finding that injections of both compounds together significantly retarded tumor growth.
- Curry and Cauliflower Could Halt Prostate Cancer
Scientists test turmeric and phenethyl isothiocyanate (PEITC) in mice, injecting the mice with cells from human prostate cancer cell lines to grow tumors against which the compounds could be tested, finding that injections of both compounds together significantly retarded tumor growth.
- Curry and Cauliflower Could Halt Prostate Cancer
Scientists test turmeric and phenethyl isothiocyanate (PEITC) in mice, injecting the mice with cells from human prostate cancer cell lines to grow tumors against which the compounds could be tested, finding that injections of both compounds together significantly retarded tumor growth.
- ImmunoLin® Improves Quality of Life in New IBS Study
Company conducted double-blind placebo controlled six week study on 51 patients, observing that overall days with symptoms decreased by 16% and 18% in the 5 gm ImmunoLin and 10 gm ImmunoLin groups, respectively, compared to the soy protein control group.
- ImmunoLin® Improves Quality of Life in New IBS Study
Company conducted double-blind placebo controlled six week study on 51 patients, observing that overall days with symptoms decreased by 16% and 18% in the 5 gm ImmunoLin and 10 gm ImmunoLin groups, respectively, compared to the soy protein control group.
- ImmunoLin® Improves Quality of Life in New IBS Study
Company conducted double-blind placebo controlled six week study on 51 patients, observing that overall days with symptoms decreased by 16% and 18% in the 5 gm ImmunoLin and 10 gm ImmunoLin groups, respectively, compared to the soy protein control group.
- ImmunoLin® Improves Quality of Life in New IBS Study
Company conducted double-blind placebo controlled six week study on 51 patients, observing that overall days with symptoms decreased by 16% and 18% in the 5 gm ImmunoLin and 10 gm ImmunoLin groups, respectively, compared to the soy protein control group.
- Human Study Shows Protandim(R) Provides a Fundamentally New Approach to Antioxidant Therapy
Company announces data from a human study just published in the journal, Free Radical Biology & Medicine, which indicate that Protandim(R) was able to reduce oxidative stress in men and women, by inducing the body to produce more of its own antioxidant enzymes.
- Human Study Shows Protandim(R) Provides a Fundamentally New Approach to Antioxidant Therapy
Company announces data from a human study just published in the journal, Free Radical Biology & Medicine, which indicate that Protandim(R) was able to reduce oxidative stress in men and women, by inducing the body to produce more of its own antioxidant enzymes.
- Study Compares Regulation of Conventional, Homeopathic Drugs; Finds Strong Similarities
A new study comparing the standards by which homeopathic medicines are regulated to conventional drugs and dietary supplements shows that homeopathic medicines undergo extensive Food and Drug Administration (FDA) pre-market evaluation that more resembles traditional pharma than dietary supplements.
- Study Compares Regulation of Conventional, Homeopathic Drugs; Finds Strong Similarities
A new study comparing the standards by which homeopathic medicines are regulated to conventional drugs and dietary supplements shows that homeopathic medicines undergo extensive Food and Drug Administration (FDA) pre-market evaluation that more resembles traditional pharma than dietary supplements.
- Natural Cold Medicine Shortens Duration of Acute Bronchitis, New Study Finds
randomized, double-blind, placebo-controlled trial, published in the medical journal EXPLORE -- The Journal of Science and Healing shows that a medicinal extract of Pelargonium sidoides roots, available in the U.S. as UMCKA COLDCARE(R), evaluated for efficacy of treatment for chronic bronchitis, resulted in complete recovery or major improvement in 85% of patients, compared to just 30% for placebo.
- Natural Cold Medicine Shortens Duration of Acute Bronchitis, New Study Finds
randomized, double-blind, placebo-controlled trial, published in the medical journal EXPLORE -- The Journal of Science and Healing shows that a medicinal extract of Pelargonium sidoides roots, available in the U.S. as UMCKA COLDCARE(R), evaluated for efficacy of treatment for chronic bronchitis, resulted in complete recovery or major improvement in 85% of patients, compared to just 30% for placebo.
- Natural Cold Medicine Shortens Duration of Acute Bronchitis, New Study Finds
randomized, double-blind, placebo-controlled trial, published in the medical journal EXPLORE -- The Journal of Science and Healing shows that a medicinal extract of Pelargonium sidoides roots, available in the U.S. as UMCKA COLDCARE(R), evaluated for efficacy of treatment for chronic bronchitis, resulted in complete recovery or major improvement in 85% of patients, compared to just 30% for placebo.
- Natural Cold Medicine Shortens Duration of Acute Bronchitis, New Study Finds
randomized, double-blind, placebo-controlled trial, published in the medical journal EXPLORE -- The Journal of Science and Healing shows that a medicinal extract of Pelargonium sidoides roots, available in the U.S. as UMCKA COLDCARE(R), evaluated for efficacy of treatment for chronic bronchitis, resulted in complete recovery or major improvement in 85% of patients, compared to just 30% for placebo.
- Natural Cold Medicine Shortens Duration of Acute Bronchitis, New Study Finds
randomized, double-blind, placebo-controlled trial, published in the medical journal EXPLORE -- The Journal of Science and Healing shows that a medicinal extract of Pelargonium sidoides roots, available in the U.S. as UMCKA COLDCARE(R), evaluated for efficacy of treatment for chronic bronchitis, resulted in complete recovery or major improvement in 85% of patients, compared to just 30% for placebo.
- Research Supports Effectiveness Of Biocell Collagen II(r) In Promoting Skin Health
Bioassay report states the effectiveness of BioCell Collagen II(r) with hyaluronic acid (HA) in inhibiting hyaluronidase.
- Research Supports Effectiveness Of Biocell Collagen II(r) In Promoting Skin Health
Bioassay report states the effectiveness of BioCell Collagen II(r) with hyaluronic acid (HA) in inhibiting hyaluronidase.
- Research Supports Effectiveness Of Biocell Collagen II(r) In Promoting Skin Health
Bioassay report states the effectiveness of BioCell Collagen II(r) with hyaluronic acid (HA) in inhibiting hyaluronidase.
- Research Supports Effectiveness Of Biocell Collagen II(r) In Promoting Skin Health
Bioassay report states the effectiveness of BioCell Collagen II(r) with hyaluronic acid (HA) in inhibiting hyaluronidase.
- Vitamin D signals to prevent bone loss during osteoporosis
In a study appearing online on January 19 in advance of print publication in the February 2006 issue of the Journal of Clinical Investigation, Japanese researchers examine mice with severe osteoporosis and show that oral vitamin D treatment inhibits the production of the protein c-Fos, which plays a role in bone breakdown and resorption.
- Vitamin D signals to prevent bone loss during osteoporosis
In a study appearing online on January 19 in advance of print publication in the February 2006 issue of the Journal of Clinical Investigation, Japanese researchers examine mice with severe osteoporosis and show that oral vitamin D treatment inhibits the production of the protein c-Fos, which plays a role in bone breakdown and resorption.
- Vitamin D signals to prevent bone loss during osteoporosis
In a study appearing online on January 19 in advance of print publication in the February 2006 issue of the Journal of Clinical Investigation, Japanese researchers examine mice with severe osteoporosis and show that oral vitamin D treatment inhibits the production of the protein c-Fos, which plays a role in bone breakdown and resorption.
- Vitamin D signals to prevent bone loss during osteoporosis
In a study appearing online on January 19 in advance of print publication in the February 2006 issue of the Journal of Clinical Investigation, Japanese researchers examine mice with severe osteoporosis and show that oral vitamin D treatment inhibits the production of the protein c-Fos, which plays a role in bone breakdown and resorption.
- Vitamin D signals to prevent bone loss during osteoporosis
In a study appearing online on January 19 in advance of print publication in the February 2006 issue of the Journal of Clinical Investigation, Japanese researchers examine mice with severe osteoporosis and show that oral vitamin D treatment inhibits the production of the protein c-Fos, which plays a role in bone breakdown and resorption.
- Fish-oil Supplements May Reduce Anger in Substance Abusers
Double-blind clinical study of omega-3 essential fatty acid (EFA) supplementation in substance abusers suggests that a patented fish-oil supplement can reduce levels of anger, thereby potentially mitigating aggressive behavior.
- Fish-oil Supplements May Reduce Anger in Substance Abusers
Double-blind clinical study of omega-3 essential fatty acid (EFA) supplementation in substance abusers suggests that a patented fish-oil supplement can reduce levels of anger, thereby potentially mitigating aggressive behavior.
- Fish-oil Supplements May Reduce Anger in Substance Abusers
Double-blind clinical study of omega-3 essential fatty acid (EFA) supplementation in substance abusers suggests that a patented fish-oil supplement can reduce levels of anger, thereby potentially mitigating aggressive behavior.
- Fish-oil Supplements May Reduce Anger in Substance Abusers
Double-blind clinical study of omega-3 essential fatty acid (EFA) supplementation in substance abusers suggests that a patented fish-oil supplement can reduce levels of anger, thereby potentially mitigating aggressive behavior.
- Study Examines Chocolate Chip Cookie with Soluble Fiber, Plant Sterols, and Impact on Cholesterol
double-blind, placebo-controlled cross-over study indicates that specially formulated chocolate chip cookie containing soluble fiber and plant sterols led to a significant decrease in total cholesterol and LDL cholesterol in patients who ate two chocolate chip Right Direction Cookies(tm) each day for 30 days.
- Study Examines Chocolate Chip Cookie with Soluble Fiber, Plant Sterols, and Impact on Cholesterol
double-blind, placebo-controlled cross-over study indicates that specially formulated chocolate chip cookie containing soluble fiber and plant sterols led to a significant decrease in total cholesterol and LDL cholesterol in patients who ate two chocolate chip Right Direction Cookies(tm) each day for 30 days.
- Kaneka Corporation Of Japan Announces Safety Study Results Of KanekaQ10(TM) On Healthy Subjects
Double blind, randomized placebo-controlled trial in Japan, published in papers at the Japan Health Medicine Association, observes that KanekaQ10 in healthy subjects was well tolerated in dosages up to 900mg per day.
- Kaneka Corporation Of Japan Announces Safety Study Results Of KanekaQ10(TM) On Healthy Subjects
Double blind, randomized placebo-controlled trial in Japan, published in papers at the Japan Health Medicine Association, observes that KanekaQ10 in healthy subjects was well tolerated in dosages up to 900mg per day.
- Study Shows Standardized White Bean Extract Reduces the GI of White Bread
Randomized, crossover study, presented at the Third Annual Natural Supplements: An Evidence-Based Update Conference, Sponsored by the Scripps Center for Integrative Medicine, indicates that at a dose of 3000 mg of Phase 2 brand white bean extract, the GI of white bread was reduced by 20.23 points, or 39.07%.
- Study Shows Standardized White Bean Extract Reduces the GI of White Bread
Randomized, crossover study, presented at the Third Annual Natural Supplements: An Evidence-Based Update Conference, Sponsored by the Scripps Center for Integrative Medicine, indicates that at a dose of 3000 mg of Phase 2 brand white bean extract, the GI of white bread was reduced by 20.23 points, or 39.07%.
- ORAFTI’S Beneo(TM)P95 Shown to Promote Satiety and to Limit Energy Intake in Humans
Pilot study in humans has demonstrated that Beneo(TM) oligofructose can act as a trigger limiting hunger feeling and energy intake.
- ORAFTI’S Beneo(TM)P95 Shown to Promote Satiety and to Limit Energy Intake in Humans
Pilot study in humans has demonstrated that Beneo(TM) oligofructose can act as a trigger limiting hunger feeling and energy intake.
- ORAFTI’S Beneo(TM)P95 Shown to Promote Satiety and to Limit Energy Intake in Humans
Pilot study in humans has demonstrated that Beneo(TM) oligofructose can act as a trigger limiting hunger feeling and energy intake.
- ORAFTI’S Beneo(TM)P95 Shown to Promote Satiety and to Limit Energy Intake in Humans
Pilot study in humans has demonstrated that Beneo(TM) oligofructose can act as a trigger limiting hunger feeling and energy intake.
- New Study Finds Cranberry Compounds Block Cancer
New study, published in this month's issue of The Journal of the Science of Food and Agriculture, shows that proanthocyanidins, or PACs, found in cranberries inhibit the growth of lung tumors and colon and leukemia cells in vitro.
- New Study Finds Cranberry Compounds Block Cancer
New study, published in this month's issue of The Journal of the Science of Food and Agriculture, shows that proanthocyanidins, or PACs, found in cranberries inhibit the growth of lung tumors and colon and leukemia cells in vitro.
- New Study Finds Cranberry Compounds Block Cancer
New study, published in this month's issue of The Journal of the Science of Food and Agriculture, shows that proanthocyanidins, or PACs, found in cranberries inhibit the growth of lung tumors and colon and leukemia cells in vitro.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Another Reason to Choose Healthy Lifestyle Habits
- Another Reason to Choose Healthy Lifestyle Habits
|
HACKETTSTOWN, N.J., Jan 17, 2006 /PRNewswire via COMTEX/ -- While a growing number of studies has shown a link between flavanol-rich cocoa and cardiovascular health, scientists have now substantiated a causal relationship between specific compounds present in cocoa and cardiovascular health. Published today in the Proceedings of the National Academy of Sciences of the United States of America (PNAS)(1), this new study identifies the flavanol, (-)epicatechin, as one of the bioactive nutrients in cocoa that can improve the ability of blood vessels to relax.
An international team of scientists from the University of Dusseldorf, Germany; the University of California, Davis; Mars, Incorporated; and Harvard Medical School conducted a series of studies examining the role of specific cocoa flavanols in cardiovascular health.
"Applying accepted causality criteria and gold standard methodologies, we have been able to advance our understanding of the relationship between the intake of certain flavanols present in cocoa, their absorption into the circulation, and their effects on cardiovascular function," said lead author Hagen Schroeter, PhD, faculty member at the University of California, Davis. "This study established direct evidence for the effect of the flavanol (-)epicatechin as a mediator of blood vessel relaxation."
In a randomized, double-blind, cross-over investigation, the researchers provided healthy male participants with a specially prepared cocoa drink that was either high or low in certain cocoa flavanols. Only the group consuming the flavanol-rich cocoa experienced increased blood vessel relaxation. The researchers demonstrated that the relaxation response mediated by cocoa flavanols is dependent on nitric oxide, a key signal released by the inner lining of blood vessels (the endothelium) essential for normal blood vessel function and healthy blood flow.
To provide direct evidence for the specific flavanol in cocoa that is partly responsible for the circulatory benefits, the research team conducted a "proof-of-concept" study. During this part of the investigation, participants drank either a placebo or a beverage containing isolated, cocoa-derived (-)epicatechin. The researchers demonstrated that the group of participants receiving the (-)epicatechin had vessel relaxation and nitric oxide responses similar to those experienced following the consumption of the flavanol-rich cocoa drink. Based on these findings, the investigators concluded that (-)epicatechin is one of the active nutrients in certain cocoas exerting the observed vascular benefits.
"Pinpointing specific nutrients responsible for the observed cardiovascular effects, as we are seeing here with (-)epicatechin, opens up new possibilities for the development of dietary or therapeutic interventions for cardiovascular disease," said co-author Norman Hollenberg, MD, PhD, professor of medicine at Harvard Medical School.
(-)Epicatechin, a nutrient that may be found in certain fruit and vegetables, green teas, red wine and purple grape juice, is especially abundant in certain cocoas. "This new insight into the bioactivity of flavanol nutrients is an important piece of information that will help us understand why diets rich in fruits and vegetables promote cardiovascular health," said co-author Carl L. Keen, PhD, professor of nutrition and internal medicine at the University of California, Davis.
To assess the potential long-term benefits of a flavanol-rich diet, the researchers studied two populations of Kuna Indians of Panama. Previous work by Dr. Norman Hollenberg has shown that hypertension is rare among the indigenous Kuna Indians living on the islands as compared to those living on the mainland. The island-dwelling Kuna Indians traditionally consume large quantities of flavanol-rich cocoa (an average of 3-4 cups daily), while those who live in the suburbs of Panama City consume very little cocoa, supporting the idea that cocoa flavanols may be responsible for the lower blood pressure in the island dwellers. Linking Dr. Hollenberg's observations to their own findings, Schroeter and colleagues found that the Kuna Indians on the island who regularly consume flavanol-rich cocoa had higher levels of flavanols, as well as higher levels of nitric oxide metabolites in their circulation compared to the mainland Indians who consume little cocoa.
"These findings suggest that frequent intake of cocoa flavanols can have biological effects with important implications for long-term cardiovascular health," said Dr. Hollenberg.
In addition to collaborating on this research, Mars, Incorporated financially supported it and provided the flavanol-rich cocoa (Cocoapro(R) cocoa powder) that was used throughout these investigations.
"After more than 15 years of commitment to cocoa science research, we are excited to see such great progress in uncovering the link between cocoa flavanols and heart health," said Harold Schmitz, PhD, chief science officer of Mars, Incorporated and co-author of the study. "Traditional cocoa processing often destroys the flavanols, but Mars technology helps to retain these naturally occurring nutrients from cocoa. This new research emphasizes the importance of understanding the potential public health applications of emerging cocoa science, which is a challenge we take very seriously at Mars."
Cocoapro(R) cocoa powder is used in Dove(R) Dark Chocolate, as well as in the new heart-healthy snack CocoaVia(TM).
For more information on the science of flavanols, visit http://www.cocoapro.com or http://www.cocoavia.com.
Mars, Incorporated is one of the world's top producers of chocolate, and with a strong commitment to health research, is the leader in the science of cocoa, chocolate and health. Mars uses patented and proprietary methods of processing cocoa beans to retain as much of their naturally occurring flavanols as possible, marking these products with the Cocoapro(R) seal, a hand holding a cocoa bean to signify the careful handling. For more information please visit http://www.chocolateinfo.com or http://www.cocoapro.com.
Mars Nutrition for Health & Well-Being, a new division of Mars North America, will develop and launch new foods, snacks, beverages and lifestyle support to better serve the nutritional and well-being needs of the consumer. The mission of the division is to be a trusted partner in healthy lifestyles, enabling consumers to look, perform and feel their best every day. Mars Nutrition for Health & Well-Being, launched in June 2004, is based in Hackettstown, NJ.
(1) Schroeter H, Heiss C, Balzer J, Kleinbongard P, Keen CL, Hollenberg NK, Sies H, Kwik-Uribe C., Schmitz HH, Kelm M. (-)Epicatechin mediates beneficial effects of flavanol-rich cocoa on vascular function in humans. Proceedings of the National Academy of Sciences of the United States of America. 2006; 108:1024-1029. Online publication: www.pnas.org/papbyrecent.shtml |